Citi analyst P.J. Juvekar raised the firm’s price target on DuPont to $82 from $75 and keeps a Buy rating on the shares. Juvekar says that while there is an inclination to go back to cyclical chemical names after having lagged in 2022, he has decided to "stay defensive" going into 2023. He believes the impact of higher rates and uncertainty of the China reopening situation is likely to continue to impact the industry. "A faster China recovery would push us towards cyclicals," Juvekar tells investors in a research note. He recommends focusing on defensive names and believes it is too early to jump into commodities.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DD:
- DuPont price target raised to $81 from $76 at Argus
- Third Point buys TJX, exits Cenovus Energy in Q3
- 3M, DuPont Face California Suit for Producing Carcinogenic Chemicals
- California AG sues DuPont, 3M over ‘toxic forever chemicals’
- DuPont price target raised to $75 from $60 at Deutsche Bank
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue